Interferent Effect of Hydroxyurea on Continuous Glucose Monitoring
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
While currently available continuous glucose monitoring (CGM) systems have continually improving accuracy that has revolutionized modern diabetes care, potential medication interferences are recognized for all available CGM systems (1). For Dexcom CGM systems, hydroxyurea was recently recognized as an interfering substance that can falsely elevate sensor glucose (SG) readings (2), but the data demonstrating this interference have not been previously published. We report a patient with type 1 diabetes taking hydroxyurea who experienced falsely elevated SG values using the Dexcom G5 and G6 CGM systems, which led to the recognition of the interferent effect of hydroxyurea. A 69-year-old woman with type 1 diabetes using an insulin pump (Medtronic Paradigm Revel 723) and real-time CGM (initially Dexcom G5, then G6) took hydroxyurea (1,000 mg daily) for treatment of essential thrombocytosis. She noted that, for approximately 6 h after taking hydroxyurea, SG measurements predictably and markedly increased, even while fasting and when the time of hydroxyurea ingestion varied. In addition, the glucose management indicator (7.6%) based on 14-day average SG (170 mg/dL) was significantly higher than concomitant glycated hemoglobin (6.3%, 45 mmol/mol), suggestive of artifactual discordance. Subsequently, the patient simultaneously wore the Dexcom G6 …
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hydroxyurea, used for myeloproliferative disorders and hematologic conditions, is one of the most recently identified interfering substances that cause a temporary increase in sensor glucose values discrepant from actual glucose values (129-134).”
From 7. Diabetes Technology: Standards of Care in Diabetes—2025 (2025) · cites this paper as [131]
Citations
Cites
Continuous glucose monitors and automated insulin dosing systems in the hospital consensus guideline
Galindo, R. J., Umpierrez, G. E., Rushakoff, R. J., Basu, A., Lohnes, S., Nichols, J. H., Spanakis, E. K., Espinoza, J., Palermo, N. E., Awadjie, D. G., et al. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820954163 · Cited by 170 · cited 1×
“source ofmeasurement error for all CGM systems (1).”
BackgroundYahouédéhou, S. C. M. A., da Guarda, C. C., Figueiredo, C. V. B., Santiago, R. P., Carvalho, S. P., Fiuza, L. M., Ndidi, U. S., de Oliveira, R. M., Carvalho, M. O. S., Nascimento, V. M. L., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0218040 · Cited by 23 · cited 1×
“One study reported increased serum glucose levels associated with hydroxyurea use among children with sickle cell anemia (4).”
BackgroundHydroxyurea derivatives as hypoglycemic agents
Goldstein, S. W., McDermott, R. E., Gibbs, E. M., & Stevenson, R. W. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00067a023 · Cited by 21
Cited by
7. Diabetes Technology: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s007 · Cited by 348
Self-citation7. Diabetes Technology: Standards of Care in Diabetes — 2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s007 · Cited by 301
Self-citation7. Diabetes Technology: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s007 · Cited by 281
Self-citation7. Diabetes Technology: Standards of Care in Diabetes—2026
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., ChallaSivaKanaka, S., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s007 · Cited by 279
Self-citationInterferences with CGM systems: practical relevance?
Heinemann, L. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211065065 · Cited by 65
Metadata
- Authors
- Szmuilowicz, E. D., & Aleppo, G.
- Affiliations
- Northwestern University (US)
- Corresponding author
- Szmuilowicz, Emily D.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2021-03-02
- Volume
- 44
- Issue
- 5
- Pages
- e89-e90
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W3135189747
- Cited by
- 23
- References
- 3
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 4 · 2023: 6 · 2022: 2 · 2021: 1
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Physical Sciences › Chemistry › Analytical Chemistry › Electrochemical sensors and biosensors
- Keywords
- hydroxyurea, continuous glucose monitoring, sensor interference, Dexcom G6, type 1 diabetes, essential thrombocythemia, insulin pump, glucose management indicator
- MeSH terms
- Blood Glucose, Humans, Hydroxyurea, Blood Glucose Self-Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interferent Effect of Hydroxyurea on Continuous Glucose Monitoring. https://app.cochat.ai/papers/10.2337/dc20-3114
- The paper
- Szmuilowicz, E. D., & Aleppo, G. (2021). Interferent Effect of Hydroxyurea on Continuous Glucose Monitoring. Diabetes Care. https://doi.org/10.2337/dc20-3114
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.